Intellectual Property Rights

The PCSO–524® compound has undergone comprehensive review by International Patent offices for the subsequent approval of its unique Extraction process and anti-inflammatory usage claims


  • Third Floor, 31 C-D Wyndham St, Central, Hong Kong  
  • +61 755 991 160
  • pharma@plink.com.au

Copyright © 2017 Pharmalink International Limited. All Rights Reserved.
WEB DESIGN